Some studies have reported elevated CCL5 and CCR5 levels in AD patients, correlating with amyloid β-protein (Aβ) deposition and increased secretion of pro-inflammatory factors IL-6 and TNF-α [49]. This evidence concerns the gene CCL5 and Alzheimer disease.